Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
American Journal of Hematology
Published October 23, 2026
New Drugs in Myelofibrosis: Incremental Progress in Symptom Management Without Disease Modification.
October 24, 2026
Medspoke
Medspoke
Leukemia
Published October 23, 2026
00:00
--:--
Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML.
October 24, 2026
Share
Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML.
https://www.medspoke.co/channel_journal?id=683&tap_id=16258
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
British Journal of Dermatology
Published October 22, 2026
British Association of Dermatologists guideline for managing fungal nail infection (onychomycosis...
October 24, 2026
Why are you reporting this TALK?
